News
-
Invokana PBS 01 Dec
Wednesday | Nov 20 2013Jannsen has announced that its Invokana (canaglifozin), an SGLT2 inhibitor for type 2 diabetes, will be.
-
Everolimus for HER2+
Tuesday | Nov 19 2013The RGH E-Bulletin for this week looks at the use of everolimus for the estimated 220,000.
-
Dispensary Corner 19 Nov 13
Tuesday | Nov 19 2013Physical activity is good for you, even if it’s somewhat unusual.
-
DDS targets men’s skincare
Tuesday | Nov 19 2013Tapping into the “rapidly growing and highly lucrative” men’s skincare category, Discount Drug Stores (DDS) is.
-
Swisse global partnership
Tuesday | Nov 19 2013Australian complementary medicines supplier Swisse Wellness has today announced a landmark collaboration with an offshoot of.
-
Chemotherapy
Tuesday | Nov 19 2013Last week in Federal Parliament, the Minister for Health Peter Dutton announced that the Coalition will.
-
Sustainable HCP force
Tuesday | Nov 19 2013AT Health Workforce Australia’s annual conference, the focus is on managing a sustainable health workforce in.
-
Earlier access urged
Tuesday | Nov 19 2013An expert group convened by the UK Medicines and Healthcare products Regulatory Agency has called for.
-
MS tablet onto PBS
Tuesday | Nov 19 2013AUBAGIO (teriflunomide) has been confirmed for PBS listing effective from 01 Dec, providing a new reimbursed.
-
Merck China push
Monday | Nov 18 2013Merck Serono has announced an €80m investment in a new pharmaceutical manufacturing facility near Shanghai, China.